ReproCELL Incorporated (4978.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 2Oct 7Oct 13Oct 16Oct 21Oct 26Oct 29Nov 4

Key dataNov 4, 2026

OpenJPY 119.00

From 52W high−39.58%

Volume1.39M

Market capJPY 10.98B

P/E (TTM)—

P/S (TTM)4.8x

Div yield—

Key dataNov 4, 2026

Open

JPY 119.00

From 52W high

−39.58%

Volume

1.39M

Market cap

JPY 10.98B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.7x

P/E (TTM)

—

RSI (14)

34.8

MomentumView details →

1D Return

−2.52%

YTD Return

−17.14%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−6.7x

EV/Sales

2.3x

P/S (TTM)

4.8x

P/B (TTM)

1.2x

ProfitabilityView details →

Gross Margin

65.47%

Net Margin

−12.86%

EBITDA Margin

−3.26%

ROE (TTM)

−3.69%

ROA (TTM)

−3.11%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

−7.32%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+10.06%

EPS CAGR 3Y

+400.00%

EBITDA YoY

—

MomentumView details →

1D Return

−2.52%

YTD Return

−17.14%

1Y Return

−31.76%

RSI (14)

34.8

vs 50D SMA

−14.53%

vs 200D SMA

−22.21%

Capital & dividendView details →

Debt/Equity

—

Current Ratio

5.12x

Quick Ratio

5.02x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.52B

Net Income (TTM)

−324.00M

Op. CF (TTM)

—

Next earningsNov 12, 2026 →

Latest newsMore news →

Japanese shares listed in the item moved on October 20, with the named stocks recording the reported closing prices and daily changes.15d ago

ReproCELL announced that it had finalized the clinical trial protocol for its GPC-1 CAR-T therapy for recurrent esophageal squamous cell carcinoma after completing consultations with Japan's Pharmaceuticals and Medical Devices Agency.16d ago

Similar companies

LONSEAL CORPORATION4224.T TAOKA CHEMICAL COMPANY,LIMITED4113.T DAISHIN CHEMICAL CO.,LTD.4629.T Rasa Industries,Ltd.4022.T Takemoto Yohki Co.,Ltd.4248.T Ultrafabrics Holdings Co.,Ltd.4235.T Find similar companies →

Latest newsMore news →

Japanese shares listed in the item moved on October 20, with the named stocks recording the reported closing prices and daily changes.15d ago ReproCELL announced that it had finalized the clinical trial protocol for its GPC-1 CAR-T therapy for recurrent esophageal squamous cell carcinoma after completing consultations with Japan's Pharmaceuticals and Medical Devices Agency.16d ago